Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02590614 · ClinicalTrials.gov registry record · NA

Genetic, Dietary and Environmental Influences on Vitamin D Metabolism

A NA study, sponsored by Milton S. Hershey Medical Center.

Completed
Registry status
NA
Development phase
412
Enrollment target

NCT02590614: Completed NA study, sponsored by Milton S. Hershey Medical Center.

NCT02590614 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 412 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02590614, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.

COMPLETED
Registry status
NA
Development phase
412 participants
Enrollment target

Study Summary

Determine differences in serum vitamin D metabolism by genetic ancestry.

Primary Outcome

Differences in the increase in fasting serum levels of vitamin D metabolite 25(OH)D3 between African American and European American ancestry pairs will be determined at 0, 1 and 2 months.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT 800 IU Vitamin D

Trial Details

FieldValue
Enrollment Target 412 participants
Start Date 2013-11
Est. Completion 2019-04-24
Phase NA
Milton S. Hershey Medical Center

396 total trials

What the finished NCT02590614 record still lists

NCT02590614 is an interventional study that assigns participants to a tested intervention. The registered 412 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT02590614 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02590614 about?

NCT02590614 is a clinical study titled "Genetic, Dietary and Environmental Influences on Vitamin D Metabolism". Determine differences in serum vitamin D metabolism by genetic ancestry.

What is the current status of trial NCT02590614?

This trial is currently completed. It is a NA study. The enrollment target is 412 participants. The study started on 2013-11. Estimated completion is 2019-04-24.

What interventions are being tested in trial NCT02590614?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), 800 IU Vitamin D (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT02590614?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02590614's enrollment target sits among peer trials

412 241st of 2000 higher than 1,759 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05993689 · 412 participants · NA

    Building TrUst and UNiting Teams Through DouLa partnErship - BUNDLE

  • NCT06699212 · 412 participants · Phase 3

    A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

  • NCT03592472 · 413 participants · Phase 3

    A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)

  • NCT06697197 · 413 participants · Phase 1

    A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02590614, the US trial registry maintained by the National Library of Medicine. NCT02590614 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.